Report from the world PH Symposium Updates 2025
July 11, 2025
This event was organized as an interim update to the World Symposium on Pulmonary Hypertension (WSPH), which has traditionally been held every five years.
This event was organized as an interim update to the World Symposium on Pulmonary Hypertension (WSPH), which has traditionally been held every five years.
I am thrilled to share that the proceedings from Task Force 1 (Patient Perspective) at the 7th World Pulmonary Hypertension Symposium (WPHS) have been published
The Saudi Association for Pulmonary Hypertension (SAPH) hosted its 17th annual conference in Riyadh, Saudi Arabia, from February 15 to 17, 2024. The conference featured
In November 2023, the PH community once again convened in the beautiful city of Barcelona for the Annual PH European Conference (APHEC). This event brought
I recently attended the 4th Baltic PH conference held in Riga, Latvia. The conference is held every second year, and they alternate the location for
[vc_row][vc_column][vc_column_text] The long awaited new ESC/ERS guidelines on the diagnosis and treatment of pulmonary hypertension was presented during the annual ESC (European Society of Cardiologists)
PHA Europe has run an annual conference for many years in a row. We usually meet in a hotel by the beach just south of
Dear Friends, Colleagues and Supporters, It is with mixed feelings that I started writing this editorial. We had hoped that thanks to various precautionary measures
Estonia, Tallinn – 01.10.2021 09:30 – 01.10.2021 20:00 [hybrid event] Years of dedication and collaboration within the pulmonary hypertension (PH) community have vastly increased our
The ERS Statement on Chronic Thromboembolic Pulmonary Hypertension (CTEPH) has now been published online in the European Respiratory Journal (ERJ) as an early view.
The first WPHD was organized in Madrid on 5 of May, 2012 and we are happy that since then we have managed to organize our
On the 5th May of 2018, we showed the international community what it is like to live with PH, continuing with our successful “Get breathless
New developments in treatments and treatment strategies for pulmonary hypertension. The two largest congresses in the fields of cardiology and respiratory medicine have taken place
Three new drugs for pulmonary hypertension have been approved by the US and/or EU regulatory authorities in the course of the last year:
PHA Europe at ESC Annual Congress, August 31-September 4, Amsterdam. PHA Europe was present at the 2013 Congress of the EUROPEAN SOCIETY OF CARDIOLOGY (ESC)